5/27/2025Recce Pharma Secures Key China Patent

5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova

5/27/2025Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...

5/27/2025Sinotau Files for HK IPO to Advance Radiopharma Innovations

5/27/2025RemeGen's Telitacicept Gains Approval in China

5/27/2025Salubris Pharma's S086 Receives Chinese Approval for Hypertension Trea...

5/27/2025DualityBio's HER3-Targeted ADC DB-1310 Shows Promising Early Results i...

5/27/2025PegBio Debuts on HKEx, Raising HK$300M to Advance GLP-1 Therapies

5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia

5/27/2025Hengrui's c-MET-Targeted ADC SHR-1826 Shows Promising Results in Phase...

5/27/2025Salubris Invests CNY 550M in Next-Gen Hypertension siRNA Therapy with ...

5/27/2025Pharma Distribution Market Steady with 5.6% Growth in the 14th FYP

5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...

5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...

5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ

5/23/2025Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...

5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/23/2025Recent Executive Moves

5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...

5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...

5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment

5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD

5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...

5/22/2025Hengrui Pharma Raises $1.27B in Hong Kong Listing

5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo

5/22/2025China's Clinical Trial Boom (Asimov Press)

5/21/2025CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...

5/21/2025CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy

5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL

5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports

Page:5/771 Total number of articles:23130: [First][<<] [3] [4] [5] [6] [7] [>>] [End]